The Pharmaceutical Mental Health Initiative (PMHI) group is made up of ABPI member companies with an interest in mental health. Its aim is to create a positive environment for the use of modern medicines to treat patients across the spectrum of serious mental illness.
The role of the PMHI Group is to represent individual member companies and the wider industry on all issues related to access to medicines for people with serious mental illnesses including; Schizophrenia, Bi-Polar Disorder and Severe and Enduring Depression.
The objectives of the PMHI are to build on existing joint working initiatives between Government, the NHS and the pharmaceutical industry and to demonstrate a shared vision of improved treatment and care of people with serious mental illness through improving the quality, standards and productivity of the NHS.
Industry and Mental Health Services Collaborative
The Industry and Mental Health Services Collaborative (IMHSeC) is a partnership between the Pharmaceutical Mental Health Initiative (PMHI), a working group of the ABPI, the Department of Health, Mental Health Directorate and the NHS Confederation.
The PMHI is a group of four pharmaceutical companies with an interest in the field of mental health.
Aims and objectives
IMHSeC is working with the Payments by Results (PbR) Quality & Outcomes group to help support the achievement of the group’s objectives in delivering a comprehensive range of indicators and outcome measures as an integral part of the Mental Health PbR system
The group is leading on a project that links outputs (eg NICE Quality Standards) to each of the 21 clusters, working across the various interested agencies and parties, collating work already carried out and focusing on producing a core set of outputs linking to outcomes by cluster/condition.
What will the output of this project will be?
A web-based resource that will advise stakeholders on the evidence-based pathways linked to the 21 clusters and will support the achievement of outcomes for people through the implementation of these interventions. The target audience will be providers and commissioners.
The consultation period on the web -based resource will take place between December 2011 and April 2012 with a list of key stakeholders in mental health.
The project is part of the PbR guidance in February 2012.
The project is aligned to the Joint Commissioning Panel, Mental Health communication and guidelines.
The Clinical Commissioning Groups (CCGs) have been made aware of the project:
The web based resource is scheduled for launch in 2012.
Who is on the project team?
Carole Green – Care Pathways and Packages Project (CPPP)
Michael Clark – NIHR School for Social Care Research, London
Ian Smyth – Pharmaceutical Mental Health Initiative (PMHI)
Miranda Stead – Mednet Consult Ltd
Steve Pilling – UCL /NICE
Karen Batty – CPPP
Clare Hilton - Humber NHS Foundation Trust
Wendy Shiels - Humber NHS Foundation Trust
If I want more information who should I contact?
For more information, please email Miranda Stead, Director Mednet (email@example.com).